For Clinical Research
OnTarget™ is available as a comprehensive service offering to reveal tumor mutations that are undetectable with other methods for for cancer diagnostic, surveillance, and screening applications.
For Pharmaceutical Research
OnTarget™ mutation detection services are available for translational research and soon will be available through our CLIA laboratory for clinical trial testing services.
For Clinical Testing
Boreal’s tests will be validated for patient sample processing through our Mountain View-based CLIA laboratory – contact us for updates on test availability.